Monday, November 19, 2012 10:11:16 AM
*Assuming 250 million shares outstanding which is probably too high.
Compare this to some other penny stocks with far less potential:
TAGG - Current market cap of $24 Million; peak was over $100 Million
MJNA - Current market cap of $71 Million; peak was $95 Million
CBIS - Current market cap of $61 Milion; peak was almost $70 Million
When you take into account what Dr. Joseph Rubinfeld, co-founder of Amgen said ("I have reviewed a great number of technologies in my 45 year career in the biopharmaceutical field, and I believe that MANF could be one of the biggest successes that I have ever seen. I believe that if we are able to further de-risk MANF with positive toxicology studies and early clinical data, the Company's new orphan drug strategy could get MANF to market rather expeditiously. MANF has the commercial potential to become a blockbuster drug.") on November 6th, do you really think that the market cap should only be $10 Million? We have plenty of other companies pre trial or offering crap to customers like the penny stocks above that are trading at upwards of $100 Million or more.
VAYK Confirms Insider Buying at Open Market • VAYK • Nov 5, 2024 10:40 AM
Rainmaker Worldwide Inc. Announces Strategic Partnership Between Miranda Water Technologies and Fleming College • RAKR • Nov 4, 2024 12:03 PM
North Bay Resources Announces Assays up to 9.5% Copper at Murex Copper Project, British Columbia • NBRI • Nov 4, 2024 9:00 AM
Rainmaker Worldwide Inc. to Assume Direct, Non-Dealer Sales of Miranda Water Technologies in U.S. and Mexico in First Quarter of 2025 • RAKR • Nov 4, 2024 8:31 AM
CBD Life Sciences Inc. (CBDL) Launches High-Demand Mushroom Gummy Line for Targeted Wellness Needs, Tapping into a Booming $20 Billion Market • CBDL • Oct 31, 2024 8:00 AM
Nerds On Site Announces Q1 Growth and New Initiatives for the Remainder of 2024 • NOSUF • Oct 31, 2024 7:01 AM